Australia Biotechnology & Medical Research

Alterity Therapeutics Ltd (ATH)

Track

Track

Alterity Therapeutics recorded a single insider purchase of 47,620 shares by Peter Ashley Marks on August 31, 2026, totaling $23,810. This acquisition occurred shortly after the company's latest results financiers. Despite this buying activity, the stock price has declined 27% over the past ninety days, currently trading near its fifty-two-week low.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Marks Peter Ashley Non-Executive Director
Transaction date
Purchase
Price
249.74
Quantity 68,050 +49.1%
Value US$3,732,374
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-08-31 B Purchase
Marks Peter Ashley
Non-Executive Director
68,050 +49.1%
249.74
US$3,732,374 		68,050 +49.1% 249.74 US$3,732,374
Explore more

More insider trading research around Alterity Therapeutics Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific